Literature DB >> 24264961

Small cells, big effects: the role of platelets in transplant vasculopathy.

Kristina L Modjeski1, Craig N Morrell.   

Abstract

Platelets are the cellular mediator of thrombosis, but also represent an important part of the immune system. Platelets store numerous pre-formed inflammatory molecules in their granules and produce immune mediators de novo upon stimulation. Activated platelets express adhesion molecules that can interact with endothelial cells and leukocytes both at the site of inflammatory insult and in the circulation. Platelets therefore drive and potentiate vascular inflammation by direct and indirect interactions with both endothelial cells and leukocytes. Platelet activation has been associated with the pathogenesis of inflammatory diseases such as atherosclerosis, arthritis, and cerebral malaria, in addition to transplant vasculopathy. In this review we will discuss immune roles for platelets in the context of transplant vascular inflammation.

Entities:  

Mesh:

Year:  2014        PMID: 24264961     DOI: 10.1007/s11239-013-0999-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  46 in total

1.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

Authors:  Yuqing Huo; Andreas Schober; S Bradley Forlow; David F Smith; Matthew Craig Hyman; Steffen Jung; Dan R Littman; Christian Weber; Klaus Ley
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

2.  Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration.

Authors:  Yonatan Ganor; Michal Besser; Naomie Ben-Zakay; Tamar Unger; Mia Levite
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

3.  Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo.

Authors:  S Massberg; G Enders; F C Matos; L I Tomic; R Leiderer; S Eisenmenger; K Messmer; F Krombach
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

4.  Platelets present antigen in the context of MHC class I.

Authors:  Lesley M Chapman; Angela A Aggrey; David J Field; Kalyan Srivastava; Sara Ture; Katsuyuki Yui; David J Topham; William M Baldwin; Craig N Morrell
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

5.  Platelets contribute to allograft rejection through glutamate receptor signaling.

Authors:  AnneMarie F Swaim; David J Field; Karen Fox-Talbot; William M Baldwin; Craig N Morrell
Journal:  J Immunol       Date:  2010-10-20       Impact factor: 5.422

6.  Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.

Authors:  K Enjyoji; J Sévigny; Y Lin; P S Frenette; P D Christie; J S Esch; M Imai; J M Edelberg; H Rayburn; M Lech; D L Beeler; E Csizmadia; D D Wagner; S C Robson; R D Rosenberg
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

7.  Clopidogrel reduces the development of transplant arteriosclerosis.

Authors:  Silke Abele; Michael Weyand; Martina Wollin; Nicola E Hiemann; Frank Harig; Teddy Fischlein; Stephan M Ensminger
Journal:  J Thorac Cardiovasc Surg       Date:  2006-05       Impact factor: 5.209

8.  Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates.

Authors:  Ichiro Koyama; Tatsuo Kawai; David Andrews; Svetlan Boskovic; Ognjenka Nadazdin; Siew Lin Wee; Hiroshi Sogawa; Dong-Li Wu; R Neal Smith; Robert B Colvin; David H Sachs; A Benedict Cosimi
Journal:  Transplantation       Date:  2004-02-15       Impact factor: 4.939

9.  Platelets and capillary injury in acute humoral rejection of renal allografts.

Authors:  Shane M Meehan; Somchai Limsrichamrern; Jose R Manaligod; Tipsuda Junsanto; Michelle A Josephson; J Richard Thistlethwaite; M Haas
Journal:  Hum Pathol       Date:  2003-06       Impact factor: 3.466

10.  Relationship between platelet activation and acute rejection after renal transplantation.

Authors:  Y Zhang; X D Zhang; L L Ma; D L Guan
Journal:  Transplant Proc       Date:  2009-06       Impact factor: 1.066

View more
  5 in total

Review 1.  Novel mediators and biomarkers of thrombosis.

Authors:  Travis Sexton; Susan S Smyth
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

2.  Testing the Efficacy of Contrast-Enhanced Ultrasound in Detecting Transplant Rejection Using a Murine Model of Heart Transplantation.

Authors:  K Fischer; S Ohori; F C Meral; M Uehara; S Giannini; T Ichimura; R N Smith; F A Jolesz; I Guleria; Y Zhang; P J White; N J McDannold; K Hoffmeister; M M Givertz; R Abdi
Journal:  Am J Transplant       Date:  2017-02-01       Impact factor: 8.086

3.  Red cell index: A novel biomarker for 3-month mortality in acute ischemic stroke patients treated with intravenous thrombolysis.

Authors:  Meizi Qian; Xinbo Zhou; Beibei Gao; Honghao Huang; Chenguang Yang; Tian Zeng; Jiamin Shen; Jingyu Hu; Fangyue Sun; Shengqi Li; Xuerong Huang; Guangyong Chen
Journal:  Brain Behav       Date:  2021-05-04       Impact factor: 2.708

4.  The incidence of aspirin resistance in heart transplantation recipients.

Authors:  Tomasz Urbanowicz; Anna Komosa; Michał Michalak; Tatiana Mularek; Veronica Cassadei; Stefan Grajek; Marek Jemielity
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-06-30

5.  Donor-derived exosomes induce specific regulatory T cells to suppress immune inflammation in the allograft heart.

Authors:  Jiangping Song; Jie Huang; Xiao Chen; Xiao Teng; Zhizhao Song; Yong Xing; Mangyuan Wang; Kai Chen; Zheng Wang; Pingchang Yang; Shengshou Hu
Journal:  Sci Rep       Date:  2016-01-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.